R. Blazquez, F. M. Sanchez-margallo, O. De-la-rosa, W. Dalemans, V. Alvarez et al., Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells.Front Immunol5, p.556, 2014.

W. Chen, Y. Huang, J. Han, L. Yu, Y. Li et al., Immunomodulatory effects of mesenchymal stromal cells-derived exosome, Immunol Res, vol.64, pp.831-840, 2016.

M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, The biology of human natural killer-cell subsets, Trends in Immunology, vol.22, pp.633-640, 2001.

A. Del-fattore, R. Luciano, L. Pascucci, B. M. Goffredo, E. Giorda et al., Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes, Cell Transplant, vol.24, pp.2615-2627, 2015.

U. M. Fischer, M. T. Harting, F. Jimenez, W. O. Monzon-posadas, H. Xue et al., Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect, Stem Cells Dev, vol.18, pp.683-691, 2009.

M. Gazdic, V. Volarevic, N. Arsenijevic, and M. Stojkovic, Mesenchymal stem cells: a friend or foe in immune-mediated diseases, Stem Cell Rev, vol.11, pp.280-287, 2015.

M. Giuliani, N. Oudrhiri, Z. M. Noman, A. Vernochet, S. Chouaib et al., Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery, Blood, vol.118, pp.3254-3262, 2011.

M. Giuliani, M. Fleury, A. Vernochet, F. Ketroussi, D. Clay et al., Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation, PLoS ONE, vol.6, 2011.

C. Götherström, O. Ringdén, M. Westgren, C. Tammik, L. Blanc et al., , 2003.

, Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells, Bone Marrow Transplant, vol.32, pp.265-272

R. Haddad, F. Saldanha-araujo, R. Haddad, and F. Saldanha-araujo, Mechanisms of T-Cell Immunosuppression by Mesenchymal Stromal Cells: What Do We Know So Far? BioMed Research International, BioMed Research International, p.216806, 2014.

H. Kim, D. Choi, S. J. Yun, S. Choi, J. W. Kang et al., Proteomic analysis of microvesicles derived from human mesenchymal stem cells, J. Proteome Res, vol.11, pp.839-849, 2012.

P. O. Krutzik and G. P. Nolan, Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events, Cytometry A, vol.55, pp.61-70, 2003.

D. Kyurkchiev, I. Bochev, E. Ivanova-todorova, M. Mourdjeva, T. Oreshkova et al., Secretion of immunoregulatory cytokines by mesenchymal stem cells, World J Stem Cells, vol.6, pp.552-570, 2014.

R. C. Lai, S. S. Tan, B. J. Teh, S. K. Sze, F. Arslan et al.,

, Proteolytic Potential of the MSC Exosome Proteome: Implications for an ExosomeMediated Delivery of Therapeutic Proteasome, Int J Proteomics, p.971907, 2012.

R. C. Lai, R. W. Yeo, and S. K. Lim, Mesenchymal stem cell exosomes, Seminars in Cell & Developmental Biology, vol.40, pp.82-88, 2015.

C. Liang, S. Chen, M. Wang, W. Zhai, Z. Zhou et al., Synergistic immunomodulatory effects of interferon-gamma and bone marrow mesenchymal stem cells, 2013.

. Zhonghuaxue-ye-xuezazhi34, , pp.213-216

F. Lv, R. S. Tuan, K. M. Cheung, and V. Y. Leung, Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells, Stem Cells, vol.32, pp.1408-1419, 2014.

A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A. Farshid et al., Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling, Immunology Letters, vol.147, pp.47-54, 2012.

J. E. Murphy-ullrich and M. Poczatek, Activation of latent TGF-? by thrombospondin-1: mechanisms and physiology, Cytokine & Growth Factor Reviews, vol.11, pp.59-69, 2000.

D. Padua and J. Massagué, Roles of TGF? in metastasis, Cell Res, vol.19, pp.89-102, 2009.

K. Park, H. Park, M. Kim, Y. Kim, K. Han et al., Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system, Biomed Res, 2013.

B. A. Pierson, K. Gupta, W. S. Hu, and J. S. Miller, Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors, Blood, vol.87, pp.180-189, 1996.

M. E. Reinders and M. J. Hoogduijn, NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation, J Stem Cell Res, 2014.

R. H. Rouce, H. Shaim, T. Sekine, G. Weber, B. Ballard et al., The TGF-?/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B acute lymphoblastic leukemia, Leukemia, vol.30, pp.800-811, 2016.

Y. Shi, J. Su, A. I. Roberts, P. Shou, A. B. Rabson et al., How mesenchymal stem cells interact with tissue immune responses, Trends, vol.33, pp.136-143, 2012.

Y. Shi, J. Su, A. I. Roberts, P. Shou, A. B. Rabson et al., How mesenchymal stem cells interact with tissue immune responses, Trends, vol.33, issue.103, pp.136-143, 2012.

M. Simons and G. Raposo, Exosomes -vesicular carriers for intercellular communication, Current Opinion in Cell Biology, vol.21, pp.575-581, 2009.

B. Suárez-Álvarez, A. López-vázquez, J. M. Baltar, F. Ortega, and C. López-larrea, , 2009.

, Potential Role of NKG2D and Its Ligands in Organ Transplantation: New Target for Immunointervention, American Journal of Transplantation, vol.9, pp.251-257

S. K. Sze, D. P. Kleijn, . De, R. C. Lai, E. K. Tan et al., Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells, Mol Cell Proteomics, vol.6, pp.1680-1689, 2007.

C. Théry, S. Amigorena, G. Raposo, C. , and A. , Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids, Current Protocols in Cell Biology, p.p, 2001.

C. Vater, P. Kasten, and M. Stiehler, Culture media for the differentiation of mesenchymal stromal cells, vol.7, pp.463-477, 2011.

L. Yang, Y. Pang, and H. L. Moses, TGF-? and immune cells: an important regulatory axis in the tumor microenvironment and progression, Trends, vol.31, pp.220-227, 2010.

B. Yu, X. Zhang, L. , and X. , Exosomes Derived from Mesenchymal Stem Cells, Int J Mol, vol.15, pp.4142-4157, 2014.

C. Sell, R. Baserga, and R. Rubin, Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis, Cancer Res, vol.55, pp.303-309, 1995.

V. M. Macaulay, Insulin-like growth factors and cancer, Br J Cancer, vol.65, pp.311-331, 1992.

D. Leroith, R. Baserga, L. Helman, R. Jr, and C. T. , Insulin-like growth factors and cancer, Ann Intern Med, vol.122, pp.54-63, 1995.

J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma et al., Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study, Science, vol.279, pp.563-569, 1998.

A. V. Lee, S. G. Hilsenbeck, and D. Yee, IGF system components as prognostic markers in breast cancer, Breast Cancer Res Treat, vol.47, pp.295-302, 1998.

M. N. Pollak, E. S. Schernhammer, and S. E. Hankinson, Insulin-like growth factors and neoplasia, Nat Rev Cancer, vol.4, pp.505-523, 2004.

J. Trojan, B. K. Blossey, T. R. Johnson, S. D. Rudin, M. Tykocinski et al., Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I, Proc Natl Acad Sci U S A, vol.89, pp.4874-4882, 1992.

M. Resnicoff, C. Sell, M. Rubini, D. Coppola, D. Ambrose et al., Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wildtype tumors, Cancer Res, vol.54, pp.2218-2240, 1994.

J. Trojan, H. T. Duc, L. C. Upegui-gonzalez, F. Hor, Y. Guo et al., Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA, Neurosci Lett, vol.212, pp.9-12, 1996.

C. Lafarge-frayssinet, H. T. Duc, C. Frayssinet, A. Sarasin, D. Anthony et al., Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression, Cancer Gene Ther, vol.4, pp.276-85, 1997.

S. Trabado, N. Van-binh, P. Martin, C. Lafarge-frayssinet, C. Thevenin et al., Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cells, Biomed Pharmacother, vol.60, pp.693-700, 2006.

S. Trabado, P. N. Van-binh, and C. Martin, Stimulation of anti-melanoma immune effectors via modified tumour cells exhibiting inhibited IGF-I and low CD9, Biomed Pharmacother, vol.61, pp.494-502, 2007.

I. J. Fidler, Biological behavior of malignant melanoma cells correlated to their survival in vivo, Cancer Res, vol.35, pp.18-24, 1975.

F. Nimmerjahn and J. V. Ravetch, Fc-receptors as regulators of immunity, Adv Immunol, vol.96, pp.179-204, 2007.

S. Chung, Y. L. Lin, and C. Reed, Characterization of in vitro antibody-dependent cell-mediated cytotoxicity of therapeutic antibodies-Impact of effector cells, J Immunol Methods, issue.14, pp.110-110, 2014.

, REFERENCES BIBLIOGRAPHIQUES

S. Aggarwal and M. F. Pittenger, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, vol.105, pp.1815-1822, 2005.

C. Akyurekli, Y. Le, R. B. Richardson, D. Fergusson, J. Tay et al., A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles, Stem Cell Rev, vol.11, pp.150-160, 2015.

S. Alsalameh, R. Amin, T. Gemba, and M. Lotz, Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage, Arthritis Rheum, vol.50, pp.1522-1532, 2004.

G. Alter, J. M. Malenfant, A. , and M. , CD107a as a functional marker for the identification of natural killer cell activity, Journal of Immunological Methods, vol.294, pp.15-22, 2004.

P. S. Anker, S. A. Scherjon, C. K. Keur, . Der, W. A. Noort et al., Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation, Blood, vol.102, pp.1548-1549, 2003.

P. S. Anker, S. A. Scherjon, C. Kleijburg-van-der-keur, G. M. De-groot-swings, F. H. Claas et al., Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta, STEM CELLS, vol.22, pp.1338-1345, 2004.

S. Asari, S. Itakura, K. Ferreri, C. Liu, Y. Kuroda et al., , 2009.

, Mesenchymal stem cells suppress B-cell terminal differentiation, Exp. Hematol, vol.37, pp.604-615

D. B. Ascon, S. Lopez-briones, M. Liu, M. Ascon, V. Savransky et al., Phenotypic and Functional Characterization of Kidney-Infiltrating Lymphocytes in Renal Ischemia Reperfusion Injury, The Journal of Immunology, vol.177, pp.3380-3387, 2006.

A. Augello, R. Tasso, S. M. Negrini, A. Amateis, F. Indiveri et al., , 2005.

, Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway, Eur. J. Immunol, vol.35, pp.1482-1490

S. R. Baglio, K. Rooijers, D. Koppers-lalic, F. J. Verweij, M. Pérez-lanzón et al., Human bone marrow-and adiposemesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species, Stem Cell Research & Therapy, vol.6, p.127, 2015.

L. Bai, D. P. Lennon, V. Eaton, K. Maier, A. I. Caplan et al., Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis, Glia, vol.57, pp.1192-1203, 2009.

A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. Mcintosh et al., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp. Hematol, vol.30, pp.42-48, 2002.

B. S. Batista, W. S. Eng, K. T. Pilobello, K. D. Hendricks-muñoz, and L. K. Mahal, Identification of a conserved glycan signature for microvesicles, J. Proteome Res, vol.10, pp.4624-4633, 2011.

D. M. Baume, M. J. Robertson, H. Levine, T. J. Manley, P. W. Schow et al., , 1992.

, Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells, Eur. J. Immunol, vol.22, pp.1-6

S. A. Bellingham, B. B. Guo, B. M. Coleman, and A. F. Hill, Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?, Front Physiol, vol.3, p.124, 2012.

D. Belotti, C. Capelli, A. Resovi, M. Introna, and G. Taraboletti, Thrombospondin-1 promotes mesenchymal stromal cell functions via TGF? and in cooperation with PDGF, Matrix Biology, vol.55, pp.106-116, 2016.

E. W. Benz and H. L. Moses, Small, virus-like particles detected in bovine sera by electron microscopy, J. Natl. Cancer Inst, vol.52, pp.1931-1934, 1974.

M. E. Bernardo and W. E. Fibbe, Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation, Cell Stem Cell, vol.13, pp.392-402, 2013.

S. Beyth, Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit et al., Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness, Blood, vol.105, pp.2214-2219, 2005.

M. E. Bianchi, DAMPs, PAMPs and alarmins: all we need to know about danger, J. Leukoc. Biol, vol.81, pp.1-5, 2007.

R. Blazquez, F. M. Sanchez-margallo, O. De-la-rosa, W. Dalemans, V. Alvarez et al., Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol, vol.5, p.556, 2014.

R. A. Boomsma and D. L. Geenen, Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis, PLoS ONE, vol.7, p.35685, 2012.

V. M. Braud, D. S. Allan, C. A. O"callaghan, K. Söderström, A. Andrea et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature, vol.391, pp.795-799, 1998.

J. J. Bright, L. D. Kerr, and S. Sriram, TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes, J. Immunol, vol.159, pp.175-183, 1997.

T. G. Brock, R. W. Mcnish, and M. Peters-golden, Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2, J. Biol. Chem, vol.274, pp.11660-11666, 1999.

S. P. Bruder, N. Jaiswal, and S. E. Haynesworth, Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation, J. Cell. Biochem, vol.64, pp.278-294, 1997.

S. Bruno, C. Grange, M. C. Deregibus, R. A. Calogero, S. Saviozzi et al., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, J. Am. Soc. Nephrol, vol.20, pp.1053-1067, 2009.

M. Budoni, A. Fierabracci, R. Luciano, S. Petrini, V. Di-ciommo et al., The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles, Cell Transplant, vol.22, pp.369-379, 2013.

S. I. Buschow, E. N. Nolte-"t-hoen, G. Van-niel, M. S. Pols, T. Ten-broeke et al., MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways, Traffic, vol.10, pp.1528-1542, 2009.

A. Byrd, S. C. Hoffmann, M. Jarahian, F. Momburg, and C. Watzl, Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44, PLoS ONE, vol.2, p.1339, 2007.

L. M. Calvi, G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson et al., Osteoblastic cells regulate the haematopoietic stem cell niche, Nature, vol.425, pp.841-846, 2003.

C. Campagnoli, I. A. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono et al., Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow, Blood, vol.98, pp.2396-2402, 2001.

D. Campard, P. A. Lysy, M. Najimi, and E. M. Sokal, Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells, Gastroenterology, vol.134, pp.833-848, 2008.

C. Capelli, E. Gotti, M. Morigi, C. Rota, L. Weng et al., Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate, Cytotherapy, vol.13, pp.786-801, 2011.

A. I. Caplan, Mesenchymal stem cells, J. Orthop. Res, vol.9, pp.641-650, 1991.

M. J. Casey and H. Meier-kriesche, Calcineurin inhibitors in kidney transplantation: friend or foe?, Curr. Opin. Nephrol. Hypertens, vol.20, pp.610-615, 2011.

F. Casiraghi, N. Perico, M. Cortinovis, and G. Remuzzi, Mesenchymal stromal cells in renal transplantation: opportunities and challenges, Nat Rev Nephrol, vol.12, pp.241-253, 2016.

R. Castriconi, C. Cantoni, M. Della-chiesa, M. Vitale, E. Marcenaro et al., Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.4120-4125, 2003.

D. Chabannes, M. Hill, E. Merieau, J. Rossignol, R. Brion et al., A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells, Blood, vol.110, pp.3691-3694, 2007.

C. Chan, K. Wu, Y. Lee, S. Hwang, M. Lee et al., The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs, Transplantation, vol.94, pp.132-138, 2012.

J. L. Chan, K. C. Tang, A. P. Patel, L. M. Bonilla, N. Pierobon et al.,

, Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma, Blood, vol.107, pp.4817-4824

P. Charbord and L. Casteilla, , 2011.

, Med Sci, vol.27, pp.261-267

P. Charbord, E. Livne, G. Gross, T. Häupl, N. M. Neves et al., Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience, Stem Cell Rev, vol.7, pp.32-42, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00465969

E. Chargaff and R. West, The biological significance of the thromboplastic protein of blood, J. Biol. Chem, vol.166, pp.189-197, 1946.

D. Charron, Allogenicity & immunogenicity in regenerative stem cell therapy, The Indian Journal of Medical Research, vol.138, p.749, 2013.

Y. Chen, Mesenchymal Stem Cell: Considerations for Manufacturing and Clinical Trials on Cell Therapy Product

K. Chen, D. Wang, W. T. Du, Z. Han, H. Ren et al., Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism, Clin. Immunol, vol.135, pp.448-458, 2010.

W. Chen, Y. Huang, J. Han, L. Yu, Y. Li et al., , 2016.

, Immunomodulatory effects of mesenchymal stromal cells-derived exosome, Immunol Res, vol.64, pp.831-840

W. W. Chen, L. Balaj, L. M. Liau, M. L. Samuels, S. K. Kotsopoulos et al., BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles, Mol Ther Nucleic Acids, vol.2, p.109, 2013.

S. Chiesa, S. Morbelli, S. Morando, M. Massollo, C. Marini et al., Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells, Proc. Natl. Acad. Sci. U.S.A, vol.108, pp.17384-17389, 2011.

R. Chinnadurai, I. B. Copland, S. R. Patel, and J. Galipeau, IDO-independent suppression of T cell effector function by IFN-?-licensed human mesenchymal stromal cells, J. Immunol, vol.192, pp.1491-1501, 2014.

H. Choi, R. H. Lee, N. Bazhanov, J. Y. Oh, and D. J. Prockop, Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-?B signaling in resident macrophages, Blood, vol.118, pp.330-338, 2011.

P. Chong, L. Selvaratnam, A. A. Abbas, and T. Kamarul, Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells, J. Orthop. Res, vol.30, pp.634-642, 2012.

H. C. Christianson, K. J. Svensson, T. H. Van-kuppevelt, J. Li, and M. Belting, Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.17380-17385, 2013.

A. Clayton, J. P. Mitchell, J. Court, S. Linnane, M. D. Mason et al., Human TumorDerived Exosomes Down-Modulate NKG2D Expression, The Journal of Immunology, vol.180, pp.7249-7258, 2008.

P. Comoli, F. Ginevri, R. Maccario, M. A. Avanzini, M. Marconi et al., Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation, Nephrol. Dial. Transplant, vol.23, pp.1196-1202, 2008.

M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, The biology of human natural killer-cell subsets, Trends in Immunology, vol.22, pp.633-640, 2001.

A. Corcione, F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello et al., Human mesenchymal stem cells modulate B-cell functions, Blood, vol.107, pp.367-372, 2006.

D. Cosman, N. Fanger, L. Borges, M. Kubin, W. Chin et al., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules, Immunity, vol.7, pp.273-282, 1997.

P. D. Cravens and P. E. Lipsky, Dendritic cells, chemokine receptors and autoimmune inflammatory diseases, Immunol. Cell Biol, vol.80, pp.497-505, 2002.

M. Crisan, M. Corselli, C. Chen, and B. Péault, Multilineage stem cells in the adult: a perivascular legacy, Organogenesis, vol.7, pp.101-104, 2011.

L. J. Crofford, COX-1 and COX-2 tissue expression: implications and predictions, J Rheumatol Suppl, vol.49, pp.15-19, 1997.

M. J. Crop, S. S. Korevaar, R. De-kuiper, J. N. Ijzermans, N. M. Van-besouw et al., Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells, Cell Transplant, vol.20, pp.1547-1559, 2011.

A. J. Cutler, V. Limbani, J. Girdlestone, and C. V. Navarrete, Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation, J. Immunol, vol.185, pp.6617-6623, 2010.

A. J. Dalton, Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles, J. Natl. Cancer Inst, vol.54, pp.1137-1148, 1975.

M. De-broe, R. Wieme, and F. Roels, Letter: Membrane fragments with koinozymic properties released from villous adenoma of the rectum, Lancet, vol.2, pp.1214-1215, 1975.

A. Del-fattore, R. Luciano, R. Saracino, G. Battafarano, C. Rizzo et al., Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells, Expert Opin Biol Ther, vol.15, pp.495-504, 2015.

A. Del-fattore, R. Luciano, L. Pascucci, B. M. Goffredo, E. Giorda et al., Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes, Cell Transplant, vol.24, pp.2615-2627, 2015.

O. Delarosa and E. Lombardo, Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential, Mediators of Inflammation, p.865601, 2010.

B. Delorme, J. Ringe, N. Gallay, Y. L. Vern, D. Kerboeuf et al., Specific plasma membrane protein phenotype of cultureamplified and native human bone marrow mesenchymal stem cells, Blood, vol.111, pp.2631-2635, 2008.

G. Deniz, G. Erten, U. C. Kücüksezer, D. Kocacik, C. Karagiannidis et al., Regulatory NK cells suppress antigen-specific T cell responses, J. Immunol, vol.180, pp.850-857, 2008.

S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew, and R. Hoffman, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood, vol.101, pp.2999-3001, 2003.

T. M. Dexter, T. D. Allen, and L. G. Lajtha, Conditions controlling the proliferation of haemopoietic stem cells in vitro, J. Cell. Physiol, vol.91, pp.335-344, 1977.

K. Dhama, M. Saminathan, S. S. Jacob, M. Singh, K. Karthik et al., Effect of Immunomodulation and Immunomodulatory Agents on Health with some Bioactive Principles, Modes of Action and Potent Biomedical Applications, International Journal of Pharmacology, vol.11, pp.253-290, 2015.

M. Di-trapani, G. Bassi, M. Midolo, A. Gatti, P. T. Kamga et al., Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions, 2016.

L. Ding, T. L. Saunders, G. Enikolopov, and S. J. Morrison, Endothelial and perivascular cells maintain haematopoietic stem cells, Nature, vol.481, pp.457-462, 2012.

F. Djouad, L. Charbonnier, C. Bouffi, P. Louis-plence, C. Bony et al., Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism, Stem Cells, vol.25, pp.2025-2032, 2007.

M. Dominici, K. Le-blanc, I. Mueller, I. Slaper-cortenbach, F. C. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-317, 2006.

M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, Mesenchymal stem cell effects on Tcell effector pathways, Stem Cell Res Ther, vol.2, p.34, 2011.

S. Dupuy, M. Lambert, D. Zucman, S. Choukem, S. Tognarelli et al., Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma, PLoS Pathog, vol.8, 2012.

H. F. Dvorak, S. C. Quay, N. S. Orenstein, A. M. Dvorak, P. Hahn et al., Tumor shedding and coagulation, Science, vol.212, pp.923-924, 1981.

E. Eggenhofer, F. Luk, M. H. Dahlke, and M. J. Hoogduijn, The life and fate of mesenchymal stem cells, Front Immunol, vol.5, p.148, 2014.

A. Eirin, S. M. Riester, X. Zhu, H. Tang, J. M. Evans et al., MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissuederived mesenchymal stem cells, Gene, vol.551, pp.55-64, 2014.

S. El-andaloussi, I. Mäger, X. O. Breakefield, and M. J. Wood, Extracellular vesicles: biology and emerging therapeutic opportunities, Nat Rev Drug Discov, vol.12, pp.347-357, 2013.

N. El-haddad, R. Moore, D. Heathcote, M. Mounayar, J. Azzi et al., The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells, J. Immunol, vol.187, pp.2252-2260, 2011.

K. English, F. P. Barry, and B. P. Mahon, Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation, Immunol. Lett, vol.115, pp.50-58, 2008.

K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry et al., Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells, Clin Exp Immunol, vol.156, pp.149-160, 2009.

K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry et al., Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells, Clin. Exp. Immunol, vol.156, pp.149-160, 2009.

K. English, A. French, and K. J. Wood, Mesenchymal stromal cells: facilitators of successful transplantation?, Cell Stem Cell, vol.7, pp.431-442, 2010.

A. Erices, P. Conget, and J. J. Minguell, Mesenchymal progenitor cells in human umbilical cord blood, British Journal of Haematology, vol.109, 2000.

T. Erkers, S. Nava, J. Yosef, O. Ringdén, and H. Kaipe, Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner, Stem Cells Dev, vol.22, pp.2596-2605, 2013.

S. Esin, G. Batoni, C. Counoupas, A. Stringaro, F. L. Brancatisano et al., Direct Binding of Human NK Cell Natural Cytotoxicity Receptor NKp44 to the Surfaces of Mycobacteria and Other Bacteria, Infect. Immun, vol.76, pp.1719-1727, 2008.

N. A. Fanger, D. Cosman, L. Peterson, S. C. Braddy, C. R. Maliszewski et al., The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes, Eur. J. Immunol, vol.28, pp.3423-3434, 1998.

A. D. Fattore, R. Luciano, A. Fierabracci, and M. Muraca, Mesenchymal stem/stromal cellderived microparticles show anti-inflammatory activity in an animal model of ulcerative colitis, Cytotherapy, vol.16, p.25, 2014.

J. Fauré, G. Lachenal, M. Court, J. Hirrlinger, C. Chatellard-causse et al., Exosomes are released by cultured cortical neurones, Mol. Cell. Neurosci, vol.31, pp.642-648, 2006.

C. Fauriat, E. O. Long, H. Ljunggren, and Y. T. Bryceson, Regulation of human NK-cell cytokine and chemokine production by target cell recognition, Blood, vol.115, pp.2167-2176, 2010.

M. Fayyad-kazan, H. Fayyad-kazan, L. Lagneaux, and M. Najar, The potential of mesenchymal stromal cells in immunotherapy, Immunotherapy, vol.8, pp.839-842, 2016.

G. Ferlazzo and B. Morandi, Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells, 2014.

G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman et al., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells, J. Exp. Med, vol.195, pp.343-351, 2002.

G. Ferlazzo, D. Thomas, S. Lin, K. Goodman, B. Morandi et al., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic, J. Immunol, vol.172, pp.1455-1462, 2004.

F. E. Figueroa, F. Carrión, S. Villanueva, and M. Khoury, Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review, Biological Research, vol.45, pp.269-277, 2012.

U. M. Fischer, M. T. Harting, F. Jimenez, W. O. Monzon-posadas, H. Xue et al., Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect, Stem Cells Dev, vol.18, pp.683-691, 2009.

D. Fitzner, M. Schnaars, D. Van-rossum, G. Krishnamoorthy, P. Dibaj et al., Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis, J. Cell. Sci, vol.124, pp.447-458, 2011.

M. B. Forman, G. W. Stone, J. , and E. K. , Role of adenosine as adjunctive therapy in acute myocardial infarction, Cardiovasc Drug Rev, vol.24, pp.116-147, 2006.

M. François, R. Romieu-mourez, S. Stock-martineau, M. Boivin, J. L. Bramson et al., Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigenpresenting cell properties, Blood, vol.114, pp.2632-2638, 2009.

M. François, R. Romieu-mourez, M. Li, and J. Galipeau, Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation, Mol. Ther, vol.20, pp.187-195, 2012.

S. François, M. Bensidhoum, M. Mouiseddine, C. Mazurier, B. Allenet et al., Local Irradiation Not Only Induces Homing of Human Mesenchymal Stem Cells at Exposed Sites but Promotes Their Widespread Engraftment to Multiple Organs: A Study of Their Quantitative Distribution After Irradiation Damage, STEM CELLS, vol.24, pp.1020-1029, 2006.

M. Franquesa, M. J. Hoogduijn, O. Bestard, and J. M. Grinyó, Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells. Front Immunol, vol.3, 2012.

M. Franquesa, F. K. Mensah, R. Huizinga, T. Strini, L. Boon et al., Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells, Stem Cells, vol.33, pp.880-891, 2015.

A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, The development of fibroblast colonies in monolayer cultures of guinea pig bone marrow and spleen cells, Cell Proliferation, vol.3, 1970.

K. Friederichs, J. Schmitz, M. Weissenbach, P. C. Heinrich, and F. Schaper, Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited, Eur. J. Biochem, vol.268, pp.6401-6407, 2001.

R. W. Garrett and S. G. Emerson, Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches, Cell Stem Cell, vol.4, pp.503-506, 2009.

G. Gasteiger, S. Hemmers, M. A. Firth, L. Floc"h, A. Huse et al., IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells, J. Exp. Med, vol.210, pp.1167-1178, 2013.

S. Gatti, S. Bruno, M. C. Deregibus, A. Sordi, V. Cantaluppi et al., , 2011.

, Microvesicles derived from human adult mesenchymal stem cells protect against ischaemiareperfusion-induced acute and chronic kidney injury, Nephrol. Dial. Transplant, vol.26, pp.1474-1483

M. Gazdic, V. Volarevic, N. Arsenijevic, and M. Stojkovic, Mesenchymal stem cells: a friend or foe in immune-mediated diseases, Stem Cell Rev, vol.11, pp.280-287, 2015.

S. Ghannam, C. Bouffi, F. Djouad, C. Jorgensen, and D. Noël, Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications, Stem Cell Res Ther, vol.1, issue.2, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-01878105

M. Giuliani, N. Oudrhiri, Z. M. Noman, A. Vernochet, S. Chouaib et al., Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery, Blood, vol.118, pp.3254-3262, 2011.

M. Giuliani, M. Fleury, A. Vernochet, F. Ketroussi, D. Clay et al., Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on TLymphocyte Proliferation, PLOS ONE, vol.6, 2011.

M. Giuliani, A. Bennaceur-griscelli, A. Nanbakhsh, N. Oudrhiri, S. Chouaib et al., TLR ligands stimulation protects MSC from NK killing, Stem Cells, vol.32, pp.290-300, 2014.

S. Glennie, I. Soeiro, P. J. Dyson, E. W. Lam, .. Dazzi et al., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, vol.105, pp.2821-2827, 2005.

M. A. González, E. Gonzalez-rey, L. Rico, D. Büscher, and M. Delgado, Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses, Gastroenterology, vol.136, pp.978-989, 2009.

C. Götherström, O. Ringdén, M. Westgren, C. Tammik, L. Blanc et al., , 2003.

, Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells, Bone Marrow Transplant, vol.32, pp.265-272

C. Götherström, A. West, J. Liden, M. Uzunel, R. Lahesmaa et al., Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells, Haematologica, vol.90, pp.1017-1026, 2005.

C. Götherström, A. Lundqvist, I. R. Duprez, R. Childs, L. Berg et al., Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways, Cytotherapy, vol.13, pp.269-278, 2011.

S. J. Gould and G. Raposo, As we wait: coping with an imperfect nomenclature for extracellular vesicles, Journal of Extracellular Vesicles, vol.2, 2013.

D. W. Greening, R. Xu, H. Ji, B. J. Tauro, and R. J. Simpson, A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods, Methods Mol. Biol, vol.1295, pp.179-209, 2015.

S. Gronthos, The therapeutic potential of dental pulp cells: more than pulp fiction?, Cytotherapy, vol.13, pp.1162-1163, 2011.

M. Guescini, S. Genedani, V. Stocchi, and L. F. Agnati, Astrocytes and Glioblastoma cells release exosomes carrying mtDNA, J Neural Transm, vol.117, pp.1-4, 2010.

R. Haddad, F. Saldanha-araujo, R. Haddad, and F. Saldanha-araujo, Mechanisms of T-Cell Immunosuppression by Mesenchymal Stromal Cells: What Do We Know So Far?, BioMed Research International, p.216806, 2014.

C. Harding, J. Heuser, and P. Stahl, Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding, Eur. J. Cell Biol, vol.35, pp.256-263, 1984.

A. Harichandan, K. Sivasubramaniyan, and H. Bühring, Prospective isolation and characterization of human bone marrow-derived MSCs, Adv. Biochem. Eng. Biotechnol, vol.129, pp.1-17, 2013.

J. He, Y. Wang, S. Sun, M. Yu, C. Wang et al., Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model, Nephrology (Carlton), vol.17, pp.493-500, 2012.

H. F. Heijnen, A. E. Schiel, R. Fijnheer, H. J. Geuze, and J. J. Sixma, Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules, Blood, vol.94, pp.3791-3799, 1999.

M. E. Hemler, Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain, Annu. Rev. Cell Dev. Biol, vol.19, pp.397-422, 2003.

Y. Heo, Y. Joo, H. Oh, M. Park, Y. Heo et al., IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients, Immunol. Lett, vol.127, pp.150-156, 2010.

R. B. Herberman, M. E. Nunn, H. T. Holden, and D. H. Lavrin, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells, Int. J. Cancer, vol.16, pp.230-239, 1975.

O. Hershkovitz, S. Jivov, N. Bloushtain, A. Zilka, G. Landau et al., Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry, vol.46, pp.7426-7436, 2007.

M. J. Hoogduijn, Are mesenchymal stromal cells immune cells?, Arthritis Res Ther, vol.17, 2015.

M. J. Hoogduijn, M. J. Crop, S. S. Korevaar, A. M. Peeters, M. Eijken et al., Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin, Transplantation, vol.86, pp.1283-1291, 2008.

W. Hsu, C. Lin, B. Chiang, H. Jui, K. K. Wu et al., Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-?+CD4+ regulatory T cells to control transplant arteriosclerosis, J. Immunol, vol.190, pp.2372-2380, 2013.

G. Hu, K. M. Drescher, C. , and X. , Exosomal miRNAs: Biological Properties and Therapeutic Potential, 2012.

H. Iguchi, N. Kosaka, and T. Ochiya, Secretory microRNAs as a versatile communication tool, Commun Integr Biol, vol.3, pp.478-481, 2010.

S. T. Ildstad and D. H. Sachs, Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts, Nature, vol.307, pp.168-170, 1984.

J. Isern, A. García-garcía, A. M. Martín, L. Arranz, D. Martín-pérez et al., The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function, vol.3, p.3696, 2014.

A. Ito, H. Shimura, A. Nitahara, K. Tomiyama, M. Ito et al., NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway, Int Immunol, vol.20, pp.1343-1349, 2008.

E. Ivanova-todorova, I. Bochev, M. Mourdjeva, R. Dimitrov, D. Bukarev et al., Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells, Immunol. Lett, vol.126, pp.37-42, 2009.

E. Ivanova-todorova, I. Bochev, R. Dimitrov, K. Belemezova, M. Mourdjeva et al., Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion, J. Biomed. Biotechnol, p.295167, 2012.

P. E. Jensen, Recent advances in antigen processing and presentation, Nat. Immunol, vol.8, pp.1041-1048, 2007.

Y. R. Ji, Z. X. Yang, Z. Han, L. Meng, L. Liang et al., Mesenchymal stem cells support proliferation and terminal differentiation of B cells, Cell. Physiol. Biochem, vol.30, pp.1526-1537, 2012.

X. Jiang, Y. Zhang, B. Liu, S. Zhang, Y. Wu et al., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, Blood, vol.105, pp.4120-4126, 2005.

R. M. Johnstone, Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins, Biochem. Cell Biol, vol.70, pp.179-190, 1991.

R. M. Johnstone, Revisiting the road to the discovery of exosomes, Molecules, and Diseases, vol.34, pp.214-219, 2005.

R. M. Johnstone, M. Adam, J. R. Hammond, L. Orr, and C. Turbide, Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes), J. Biol. Chem, vol.262, pp.9412-9420, 1987.

D. L. Jones and A. J. Wagers, No place like home: anatomy and function of the stem cell niche, Nat Rev Mol Cell Biol, vol.9, pp.11-21, 2008.

S. M. Kaech, E. J. Wherry, A. , and R. , Effector and memory T-cell differentiation: implications for vaccine development, Nat. Rev. Immunol, vol.2, pp.251-262, 2002.

P. Kalinski, Regulation of Immune Responses by Prostaglandin E2, Journal of Immunology, p.21, 1950.

H. Kalra, C. G. Adda, M. Liem, C. Ang, A. Mechler et al., Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma, Proteomics, vol.13, pp.3354-3364, 2013.

S. Kang, N. Shinojima, A. Hossain, J. Gumin, R. L. Yong et al., Isolation and Perivascular Localization of Mesenchymal Stem Cells From Mouse Brain, Neurosurgery, vol.67, pp.711-720, 2010.

B. A. Kansy, P. A. Dißmann, H. Hemeda, K. Bruderek, A. M. Westerkamp et al., The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer, Stem Cell Res Ther, vol.5, p.95, 2014.

H. Karlsson, S. Samarasinghe, L. M. Ball, B. Sundberg, A. C. Lankester et al., Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses, Blood, vol.112, pp.532-541, 2008.

A. E. Karnoub, A. B. Dash, A. P. Vo, A. Sullivan, M. W. Brooks et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.449, pp.557-563, 2007.

Y. Katayama, M. Battista, W. Kao, A. Hidalgo, A. J. Peired et al., Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow, Cell, vol.124, pp.407-421, 2006.

A. M. Katsha, S. Ohkouchi, H. Xin, M. Kanehira, R. Sun et al., , 2011.

, Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model, Mol. Ther, vol.19, pp.196-203

T. Katsuda, R. Tsuchiya, N. Kosaka, Y. Yoshioka, K. Takagaki et al., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes, Sci Rep, vol.3, p.1197, 2013.

M. L. Khoo, B. Shen, H. Tao, and D. D. Ma, Long-term serial passage and neuronal differentiation capability of human bone marrow mesenchymal stem cells, Stem Cells Dev, vol.17, pp.883-896, 2008.

R. Kiessling, E. Klein, and H. Wigzell, Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol, vol.5, pp.112-117, 1975.

L. Kilpinen, U. Impola, L. Sankkila, I. Ritamo, M. Aatonen et al., Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning, J Extracell Vesicles, vol.2, 2013.

N. Kim and S. Cho, Clinical applications of mesenchymal stem cells, Korean J. Intern. Med, vol.28, pp.387-402, 2013.

N. Kim and S. Cho, Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications, Int J Hematol, vol.103, pp.129-137, 2016.

H. Kim, D. Choi, S. J. Yun, S. Choi, J. W. Kang et al., Proteomic analysis of microvesicles derived from human mesenchymal stem cells, J. Proteome Res, vol.11, pp.839-849, 2012.

A. Kimura and T. Kishimoto, IL-6: regulator of Treg/Th17 balance, Eur. J. Immunol, vol.40, pp.1830-1835, 2010.

T. Kishimoto, IL-6: from its discovery to clinical applications, Int. Immunol, vol.22, pp.347-352, 2010.

E. Klyushnenkova, J. D. Mosca, V. Zernetkina, M. K. Majumdar, K. J. Beggs et al., T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J. Biomed. Sci, vol.12, pp.47-57, 2005.

D. Koppers-lalic, M. Hackenberg, I. V. Bijnsdorp, M. A. Van-eijndhoven, P. Sadek et al., Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes, Cell Rep, vol.8, pp.1649-1658, 2014.

L. Kordelas, V. Rebmann, A. Ludwig, S. Radtke, J. Ruesing et al., MSC-derived exosomes: a novel tool to treat therapyrefractory graft-versus-host disease, Leukemia, vol.28, pp.970-973, 2014.

M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor et al., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, vol.101, pp.3722-3729, 2003.

M. Krampera, L. Cosmi, R. Angeli, A. Pasini, F. Liotta et al., Role for Interferon-? in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells, STEM CELLS, vol.24, pp.386-398, 2006.

M. Krampera, L. Cosmi, R. Angeli, A. Pasini, F. Liotta et al., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, vol.24, pp.386-398, 2006.

P. O. Krutzik and G. P. Nolan, Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events, Cytometry A, vol.55, pp.61-70, 2003.

L. Kucerova, M. Matuskova, K. Hlubinova, V. Altanerova, A. et al., Tumor cell behaviour modulation by mesenchymal stromal cells, Mol. Cancer, vol.9, p.129, 2010.

D. Kyurkchiev, E. Ivanova-todorova, I. Bochev, M. Mourdjeva, and S. Kyurkchiev, , 2013.

, Differences Between Adipose Tissue-Derived Mesenchymal Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells as Regulators of the Immune Response, In Stem Cells and Cancer Stem Cells, vol.10, pp.71-84

D. Kyurkchiev, I. Bochev, E. Ivanova-todorova, M. Mourdjeva, T. Oreshkova et al., Secretion of immunoregulatory cytokines by mesenchymal stem cells, World J Stem Cells, vol.6, pp.552-570, 2014.

F. W. Lai, B. D. Lichty, and D. M. Bowdish, Microvesicles: ubiquitous contributors to infection and immunity, J. Leukoc. Biol, vol.97, pp.237-245, 2015.

R. C. Lai, F. Arslan, S. S. Tan, B. Tan, A. Choo et al., Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles, J. Mol. Cell. Cardiol, vol.48, pp.1215-1224, 2010.

R. C. Lai, F. Arslan, M. M. Lee, N. S. Sze, A. Choo et al., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, Stem Cell Res, vol.4, pp.214-222, 2010.

R. C. Lai, S. S. Tan, B. J. Teh, S. K. Sze, F. Arslan et al., , 2012.

, Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome, Int J Proteomics, p.971907, 2012.

R. C. Lai, R. W. Yeo, S. S. Tan, B. Zhang, Y. Yin et al., , 2013.

, Mesenchymal Stem Cell Exosomes: The Future MSC-Based Therapy?, Mesenchymal Stem Cell Therapy, pp.39-61

R. C. Lai, R. W. Yeo, and S. K. Lim, Mesenchymal stem cell exosomes, Seminars in Cell & Developmental Biology, vol.40, pp.82-88, 2015.

V. N. Lama, L. Smith, L. Badri, A. Flint, A. Andrei et al., Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts, J Clin Invest, vol.117, pp.989-996, 2007.

L. L. Lanier, Up on the tightrope: natural killer cell activation and inhibition, Nat. Immunol, vol.9, pp.495-502, 2008.

L. L. Lanier, B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips, Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells, Nature, vol.391, pp.703-707, 1998.

J. R. Lavoie and M. Rosu-myles, Uncovering the secretes of mesenchymal stem cells, Biochimie, vol.95, pp.2212-2221, 2013.

E. Lázaro-ibáñez, A. Sanz-garcia, T. Visakorpi, C. Escobedo-lucea, P. Siljander et al., Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes, Prostate, vol.74, pp.1379-1390, 2014.

L. Blanc, K. Tammik, L. Sundberg, B. Haynesworth, S. E. Ringdén et al., Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex, Scandinavian Journal of Immunology, vol.57, pp.11-20, 2003.

C. Lee, S. A. Mitsialis, M. Aslam, S. H. Vitali, E. Vergadi et al., Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension, Circulation, vol.126, pp.2601-2611, 2012.

D. Lee, T. G. Yi, H. Lee, S. Kim, S. Park et al., , 2014.

, Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes, Cell Death Dis, vol.5, p.1192

J. Lee, K. Lee, D. Kim, and D. S. Heo, Elevated TGF-beta1 secretion and downmodulation of NKG2D underlies impaired NK cytotoxicity in cancer patients, J. Immunol, vol.172, pp.7335-7340, 2004.

J. Lei, Z. Wang, D. Hui, W. Yu, D. Zhou et al., Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity, Cell. Immunol, vol.271, pp.147-156, 2011.

Y. Lepelletier, S. Lecourt, A. Renand, B. Arnulf, V. Vanneaux et al., Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell, Stem Cells Dev, vol.19, pp.1075-1079, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00437292

S. S. Li, S. K. Kyei, M. Timm-mccann, H. Ogbomo, G. J. Jones et al., The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients, Cell Host Microbe, vol.14, pp.387-397, 2013.

W. Li, G. Ren, Y. Huang, J. Su, Y. Han et al., , 2012.

, Mesenchymal stem cells: a double-edged sword in regulating immune responses, Cell Death Differ, vol.19, pp.1505-1513

X. Li, F. Arslan, Y. Ren, S. S. Adav, K. K. Poh et al., Metabolic adaptation to a disruption in oxygen supply during myocardial ischemia and reperfusion is underpinned by temporal and quantitative changes in the cardiac proteome, J. Proteome Res, vol.11, pp.2331-2346, 2012.

C. Liang, S. Chen, M. Wang, W. Zhai, Z. Zhou et al., Synergistic immunomodulatory effects of interferon-gamma and bone marrow mesenchymal stem cells, 2013.

, Zhonghua Xue Ye Xue Za Zhi, vol.34, pp.213-216

W. Liu, J. Liu, J. Wu, L. Zhang, F. Liu et al., Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway, PLoS ONE, vol.8, p.55487, 2013.

H. G. Ljunggren and K. Kärre, In search of the "missing self": MHC molecules and NK cell recognition, Immunol. Today, vol.11, pp.237-244, 1990.

H. Ljunggren and K. Malmberg, Prospects for the use of NK cells in immunotherapy of human cancer, Nat. Rev. Immunol, vol.7, pp.329-339, 2007.

M. Llano, N. Lee, F. Navarro, P. García, J. P. Albar et al., , 1998.

, HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer, Eur. J. Immunol, vol.28, pp.2854-2863

E. O. Long, D. F. Barber, D. N. Burshtyn, M. Faure, M. Peterson et al., Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158), Immunol. Rev, vol.181, pp.223-233, 2001.

M. A. Lopez-verrilli, A. Caviedes, A. Cabrera, S. Sandoval, U. Wyneken et al., , 2016.

, Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth, Neuroscience, vol.320, pp.129-139

M. Lundholm, M. Schröder, O. Nagaeva, V. Baranov, A. Widmark et al., Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion, PLoS ONE, vol.9, 2014.

J. Lüthje, Origin, metabolism and function of extracellular adenine nucleotides in the blood, Klin. Wochenschr, vol.67, pp.317-327, 1989.

P. Luz-crawford, M. Kurte, J. Bravo-alegría, R. Contreras, E. Nova-lamperti et al., , 2013.

F. Lv, R. S. Tuan, K. M. Cheung, and V. Y. Leung, Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells, Stem Cells, vol.32, pp.1408-1419, 2014.

E. M. Mace, P. Dongre, H. Hsu, P. Sinha, A. M. James et al., Cell biological steps and checkpoints in accessing, NK cell cytotoxicity. Immunol. Cell Biol, vol.92, pp.245-255, 2014.

M. K. Majumdar, M. Keane-moore, D. Buyaner, W. B. Hardy, M. A. Moorman et al., Characterization and functionality of cell surface molecules on human mesenchymal stem cells, J. Biomed. Sci, vol.10, pp.228-241, 2003.

I. Marigo and F. Dazzi, The immunomodulatory properties of mesenchymal stem cells, Semin Immunopathol, vol.33, p.593, 2011.

S. Mathivanan, H. Ji, and R. J. Simpson, Exosomes: Extracellular organelles important in intercellular communication, Journal of Proteomics, vol.73, pp.1907-1920, 2010.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu. Rev. Immunol, vol.30, pp.221-241, 2012.

L. Meirelles, S. Da, A. M. Fontes, D. T. Covas, and A. I. Caplan, Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev, vol.20, pp.419-427, 2009.

R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener et al., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, vol.103, pp.4619-4621, 2004.

S. M. Melief, E. Schrama, M. H. Brugman, M. M. Tiemessen, M. J. Hoogduijn et al., Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages, Stem Cells, vol.31, 1980.

S. M. Melief, S. B. Geutskens, W. E. Fibbe, and H. Roelofs, Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6, Haematologica, vol.98, pp.888-895, 2013.

S. Méndez-ferrer, T. V. Michurina, F. Ferraro, A. R. Mazloom, B. D. Macarthur et al., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature, vol.466, pp.829-834, 2010.

M. De-menthon, M. Lambert, E. Guiard, S. Tognarelli, B. Bienvenu et al., Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener"s), Arthritis Rheum, vol.63, pp.2116-2126, 2011.

L. Mincheva-nilsson and V. Baranov, Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance, Semin. Cancer Biol, vol.28, pp.24-30, 2014.

K. C. Miranda, D. T. Bond, J. Z. Levin, X. Adiconis, A. Sivachenko et al., Massively Parallel Sequencing of Human Urinary Exosome/Microvesicle RNA Reveals a Predominance of Non-Coding RNA, PLOS ONE, vol.9, p.96094, 2014.

S. Mocellin, F. M. Marincola, Y. , and H. A. , Interleukin-10 and the immune response against cancer: a counterpoint, J. Leukoc. Biol, vol.78, pp.1043-1051, 2005.

A. Moffett and F. Colucci, Uterine NK cells: active regulators at the maternal-fetal interface, J. Clin. Invest, vol.124, pp.1872-1879, 2014.

A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A. Farshid et al., , 2012.

, Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling, Immunology Letters, vol.147, pp.47-54

A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A. Farshid et al., , 2012.

, Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling, Immunol. Lett, vol.147, pp.47-54

O. Morel, N. Morel, L. Jesel, J. Freyssinet, and F. Toti, Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis, Semin Immunopathol, vol.33, pp.469-486, 2011.

A. E. Morelli, A. T. Larregina, W. J. Shufesky, M. L. Sullivan, D. B. Stolz et al., Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells, Blood, vol.104, pp.3257-3266, 2004.

A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni et al., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis, Annu. Rev. Immunol, vol.19, pp.197-223, 2001.

S. J. Morrison and D. T. Scadden, The bone marrow niche for haematopoietic stem cells, Nature, vol.505, pp.327-334, 2014.

J. E. Murphy-ullrich and M. Poczatek, Activation of latent TGF? by thrombospondin-1: mechanisms and physiology, Cytokine & Growth Factor Reviews, vol.11, pp.59-69, 2000.

J. E. Murphy-ullrich and M. Poczatek, Activation of latent TGF? by thrombospondin-1: mechanisms and physiology, Cytokine & Growth Factor Reviews, vol.11, pp.59-69, 2000.

A. Nagler, L. L. Lanier, S. Cwirla, and J. H. Phillips, Comparative studies of human FcRIIIpositive and negative natural killer cells, J. Immunol, vol.143, pp.3183-3191, 1989.

M. Najar, G. Raicevic, H. Id-boufker, B. Stamatopoulos, C. De-bruyn et al., Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions, Exp. Hematol, vol.38, pp.922-932, 2010.

M. Najar, G. Raicevic, H. Fayyad-kazan, H. F. Kazan, C. De-bruyn et al., Immune-related antigens, surface molecules and regulatory factors in humanderived mesenchymal stromal cells: the expression and impact of inflammatory priming, Stem Cell Rev, vol.8, pp.1188-1198, 2012.

M. Najimi, D. N. Khuu, P. A. Lysy, N. Jazouli, J. Abarca et al., , 2007.

, Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?, Cell Transplant, vol.16, pp.717-728

A. Nasef, A. Chapel, C. Mazurier, S. Bouchet, M. Lopez et al., Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells, Gene Expr, vol.13, pp.217-226, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00484862

A. Nasef, C. Mazurier, S. Bouchet, S. François, A. Chapel et al., Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression, Cell. Immunol, vol.253, pp.16-22, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00484858

A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe, Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells, J. Immunol, vol.177, pp.2080-2087, 2006.

S. Nedvetzki, S. Sowinski, R. A. Eagle, J. Harris, F. Vély et al., Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses, Blood, vol.109, pp.3776-3785, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00165508

K. Németh, A. Leelahavanichkul, P. S. Yuen, B. Mayer, A. Parmelee et al., Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat. Med, vol.15, pp.42-49, 2009.

T. H. Ng, G. J. Britton, E. V. Hill, J. Verhagen, B. R. Burton et al., Regulation of adaptive immunity; the role of interleukin-10, p.129, 2013.

M. D. Nicola, C. Carlo-stella, M. Magni, M. Milanesi, P. D. Longoni et al., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, vol.99, pp.3838-3843, 2002.

G. Van-niel, G. Raposo, C. Candalh, M. Boussac, R. Hershberg et al., Intestinal epithelial cells secrete exosome-like vesicles, Gastroenterology, vol.121, pp.337-349, 2001.

G. Van-niel, I. Porto-carreiro, S. Simoes, and G. Raposo, Exosomes: a common pathway for a specialized function, J. Biochem, vol.140, pp.13-21, 2006.

E. N. Nolte-"t-hoen, H. P. Buermans, M. Waasdorp, W. Stoorvogel, M. H. Wauben et al., Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions, Nucleic Acids Res, vol.40, pp.9272-9285, 2012.

H. Obara, K. Nagasaki, C. L. Hsieh, Y. Ogura, C. O. Esquivel et al., IFN-?, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses, American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol.5, 2005.

K. O"donoghue and N. M. Fisk, Fetal stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology, vol.18, pp.853-875, 2004.

K. Ogasawara, J. Benjamin, R. Takaki, J. H. Phillips, and L. L. Lanier, A role for NKG2D in NK cell-mediated rejection of mouse bone marrow grafts, Nat Immunol, vol.6, pp.938-945, 2005.

E. N. Olivier, A. C. Rybicki, and E. E. Bouhassira, Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells, Stem Cells, vol.24, pp.1914-1922, 2006.

M. Owen and A. J. Friedenstein, Stromal stem cells: marrow-derived osteogenic precursors, Ciba Found. Symp, vol.136, pp.42-60, 1988.

D. Padua and J. Massagué, Roles of TGF? in metastasis, Cell Res, vol.19, pp.89-102, 2009.

B. T. Pan, K. Teng, C. Wu, M. Adam, and R. M. Johnstone, Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes, J. Cell Biol, vol.101, pp.942-948, 1985.

S. Pant, H. Hilton, and M. E. Burczynski, The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities, Biochem. Pharmacol, vol.83, pp.1484-1494, 2012.

C. W. Park, K. Kim, S. Bae, H. K. Son, P. Myung et al., Cytokine secretion profiling of human mesenchymal stem cells by antibody array, Int J Stem Cells, vol.2, pp.59-68, 2009.

K. Park, H. Park, M. Kim, Y. Kim, K. Han et al., Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system, Biomed Res Int, p.210726, 2013.

M. Park, S. Kwok, S. Lee, E. Kim, S. Park et al., Adipose tissuederived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus, Cell Transplant, vol.24, pp.2367-2377, 2015.

D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-lawson, M. A. Van-eijndhoven, E. S. Hopmans et al., Functional delivery of viral miRNAs via exosomes, Proc. Natl. Acad. Sci. U.S.A, vol.107, pp.6328-6333, 2010.

B. A. Pierson, K. Gupta, W. S. Hu, and J. S. Miller, Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors, Blood, vol.87, pp.180-189, 1996.

M. F. Pittenger, A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas et al., Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science, vol.284, pp.143-147, 1999.

L. Prantl, F. Muehlberg, N. M. Navone, Y. Song, J. Vykoukal et al., Adipose tissue-derived stem cells promote prostate tumor growth, Prostate, vol.70, pp.1709-1715, 2010.

D. J. Prockop, Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation, Stem Cells, vol.31, pp.2042-2046, 2013.

V. Prod"homme, C. Griffin, R. J. Aicheler, E. C. Wang, B. P. Mcsharry et al., The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells, J. Immunol, vol.178, pp.4473-4481, 2007.

K. R. Qazi, U. Gehrmann, E. Domange-jordö, M. C. Karlsson, and S. Gabrielsson, Antigenloaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism, Blood, vol.113, pp.2673-2683, 2009.

H. Qian, H. Yang, W. Xu, Y. Yan, Q. Chen et al., Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells, Int. J. Mol. Med, vol.22, pp.325-332, 2008.

M. E. Quaedackers, C. C. Baan, W. Weimar, and M. J. Hoogduijn, Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes, Eur. J. Immunol, vol.39, pp.3436-3446, 2009.

B. Quah and H. C. Neill, Review: the application of dendritic cell-derived exosomes in tumour immunotherapy, Cancer Biother. Radiopharm, vol.15, pp.185-194, 2000.

R. Ramasamy, H. Fazekasova, E. W. Lam, .. Soeiro, I. Lombardi et al., , 2007.

, Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle, Transplantation, vol.83, pp.71-76

S. Rana, S. Yue, D. Stadel, and M. Zöller, Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection, Int. J. Biochem. Cell Biol, vol.44, pp.1574-1584, 2012.

G. Raposo and W. Stoorvogel, Extracellular vesicles: Exosomes, microvesicles, and friends, J Cell Biol, vol.200, pp.373-383, 2013.

G. Raposo and W. Stoorvogel, Extracellular vesicles: exosomes, microvesicles, and friends, J. Cell Biol, vol.200, pp.373-383, 2013.

G. Raposo, H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding et al., B lymphocytes secrete antigen-presenting vesicles, J. Exp. Med, vol.183, pp.1161-1172, 1996.

I. Rasmusson, O. Ringdén, B. Sundberg, L. Blanc, and K. , Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Experimental Cell Research, vol.305, pp.33-41, 2005.

I. Rasmusson, K. Le-blanc, B. Sundberg, and O. Ringdén, Mesenchymal stem cells stimulate antibody secretion in human B cells, Scand. J. Immunol, vol.65, pp.336-343, 2007.

J. Ratajczak, K. Miekus, M. Kucia, J. Zhang, R. Reca et al., , 2006.

, Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery, Leukemia, vol.20, pp.847-856

R. R. Redfield, E. Rodriguez, R. Parsons, K. Vivek, M. M. Mustafa et al., Essential role for B cells in transplantation tolerance, Curr. Opin. Immunol, vol.23, pp.685-691, 2011.

M. E. Reinders and M. J. Hoogduijn, NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation, J Stem Cell Res Ther, vol.4, 2014.

M. E. Reinders and M. J. Hoogduijn, NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation, J Stem Cell Res Ther, vol.4, 2014.

C. Reis-e-sousa, Dendritic cells in a mature age, Nat. Rev. Immunol, vol.6, pp.476-483, 2006.

G. Ren, J. Su, L. Zhang, X. Zhao, W. Ling et al., Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression, Stem Cells, vol.27, pp.1954-1962, 2009.

G. Ren, X. Zhao, L. Zhang, J. Zhang, A. Huillier et al., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression, J. Immunol, vol.184, pp.2321-2328, 2010.

P. Renner, E. Eggenhofer, A. Rosenauer, F. C. Popp, J. F. Steinmann et al., Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function, Transplant. Proc, vol.41, pp.2607-2611, 2009.

I. Roberts, Mesenchymal stem cells, Vox Sanguinis, vol.87, pp.38-41, 2004.

M. J. Robertson and J. Ritz, Biology and clinical relevance of human natural killer cells, Blood, vol.76, pp.2421-2438, 1990.

M. J. Robertson, T. J. Manley, C. Donahue, H. Levine, and J. Ritz, Costimulatory signals are required for optimal proliferation of human natural killer cells, J. Immunol, vol.150, pp.1705-1714, 1993.

P. A. Roche and K. Furuta, The ins and outs of MHC class II-mediated antigen processing and presentation, Nat. Rev. Immunol, vol.15, pp.203-216, 2015.

G. Ronquist, I. Brody, A. Gottfries, and B. Stegmayr, An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic fluid: part I, Andrologia, vol.10, pp.261-272, 1978.

M. M. Rosado, M. E. Bernardo, M. Scarsella, A. Conforti, E. Giorda et al., Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells, Stem Cells Dev, vol.24, pp.93-103, 2015.

G. M. Rosano, M. Fini, G. Caminiti, and G. Barbaro, Cardiac metabolism in myocardial ischemia, Curr. Pharm. Des, vol.14, pp.2551-2562, 2008.

R. H. Rouce, H. Shaim, T. Sekine, G. Weber, B. Ballard et al., The TGF-?/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B acute lymphoblastic leukemia, Leukemia, vol.30, pp.800-811, 2016.

V. Sabapathy, S. Ravi, V. Srivastava, A. Srivastava, and S. Kumar, Long-Term Cultured Human Term Placenta-Derived Mesenchymal Stem Cells of Maternal Origin Displays Plasticity, Stem Cells Int, 2012.

B. Sacchetti, A. Funari, S. Michienzi, S. Di-cesare, S. Piersanti et al., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment, Cell, vol.131, pp.324-336, 2007.

S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, Regulatory T Cells and Immune Tolerance, Cell, vol.133, pp.775-787, 2008.

I. Sánchez-berná, C. Santiago-díaz, J. , and J. , Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases, Medicina Clínica (English Edition), vol.144, pp.88-91, 2015.

K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka et al., , 2007.

, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, vol.109, pp.228-234

J. Scheller, A. Chalaris, D. Schmidt-arras, R. , and S. , The pro-and antiinflammatory properties of the cytokine interleukin-6, Biochim. Biophys. Acta, vol.1813, pp.878-888, 2011.

F. Schena, C. Gambini, A. Gregorio, M. Mosconi, D. Reverberi et al., Interferon-?-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus, Arthritis Rheum, vol.62, pp.2776-2786, 2010.

C. M. Schürch, C. Riether, and A. F. Ochsenbein, , 2014.

C. Shi and E. G. Pamer, Monocyte recruitment during infection and inflammation, Nat. Rev. Immunol, vol.11, pp.762-774, 2011.

Y. Shi, G. Hu, J. Su, W. Li, Q. Chen et al., , 2010.

, Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair, Cell Res, vol.20, pp.510-518

Y. Shi, J. Su, A. I. Roberts, P. Shou, A. B. Rabson et al., How mesenchymal stem cells interact with tissue immune responses, Trends Immunol, vol.33, pp.136-143, 2012.

Y. Shi, J. Su, A. I. Roberts, P. Shou, A. B. Rabson et al., How mesenchymal stem cells interact with tissue immune responses, Trends Immunol, vol.33, pp.136-143, 2012.

V. R. Simhadri, K. S. Reiners, H. P. Hansen, D. Topolar, V. L. Simhadri et al., Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function, PLoS ONE, vol.3, p.3377, 2008.

M. Simons and G. Raposo, Exosomes -vesicular carriers for intercellular communication, Current Opinion in Cell Biology, vol.21, pp.575-581, 2009.

M. Sioud, A. Mobergslien, A. Boudabous, and Y. Fløisand, Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation, Scand. J. Immunol, vol.71, pp.267-274, 2010.

S. Sivori, S. Carlomagno, S. Pesce, A. Moretta, M. Vitale et al., , 2014.

. Tlr/ncr/kir, Which One to Use and When? Front Immunol 5

D. Skokos, H. Goubran-botros, M. Roa, and S. Mécheri, Immunoregulatory properties of mast cell-derived exosomes, Mol. Immunol, vol.38, pp.1359-1362, 2002.

J. P. Sluijter, V. Verhage, J. C. Deddens, F. Van-den-akker, and P. A. Doevendans, , 2014.

, Microvesicles and exosomes for intracardiac communication, Cardiovasc. Res, vol.102, pp.302-311

P. A. Sotiropoulou, S. A. Perez, A. D. Gritzapis, C. N. Baxevanis, and M. Papamichail, , 2006.

, Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells. STEM CELLS, vol.24, pp.74-85

G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, vol.107, pp.1484-1490, 2006.

G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari et al., , 2008.

, Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2, Blood, vol.111, pp.1327-1333

G. M. Spaggiari, H. Abdelrazik, F. Becchetti, and L. Moretta, MSCs inhibit monocytederived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2, Blood, vol.113, pp.6576-6583, 2009.

G. M. Spaggiari, H. Abdelrazik, F. Becchetti, and L. Moretta, MSCs inhibit monocytederived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2, Blood, vol.113, pp.6576-6583, 2009.

A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, Am. J. Physiol. Endocrinol. Metab, vol.285, pp.433-437, 2003.

B. Stegmayr and G. Ronquist, Promotive effect on human sperm progressive motility by prostasomes, Urol. Res, vol.10, pp.253-257, 1982.

S. Stoumpos, A. G. Jardine, and P. B. Mark, Cardiovascular morbidity and mortality after kidney transplantation, Transpl. Int, vol.28, pp.10-21, 2015.

B. Suárez-Álvarez, A. López-vázquez, J. M. Baltar, F. Ortega, and C. López-larrea, , 2009.

, Potential Role of NKG2D and Its Ligands in Organ Transplantation: New Target for Immunointervention, American Journal of Transplantation, vol.9, pp.251-257

T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches, Immunity, vol.25, pp.977-988, 2006.

C. Sun, B. Fu, Y. Gao, X. Liao, R. Sun et al., TGF-?1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence, PLoS Pathog, vol.8, 2012.

S. K. Sze, D. P. Kleijn, . De, R. C. Lai, E. K. Tan et al., Elucidating the Secretion Proteome of Human Embryonic Stem Cellderived Mesenchymal Stem Cells, Mol Cell Proteomics, vol.6, pp.1680-1689, 2007.

S. Tabera, J. A. Pérez-simón, M. Díez-campelo, L. I. Sánchez-abarca, B. Blanco et al., The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes, Haematologica, vol.93, pp.1301-1309, 2008.

R. Taichman, M. Reilly, R. Verma, K. Ehrenman, E. et al., Hepatocyte growth factor is secreted by osteoblasts and cooperatively permits the survival of haematopoietic progenitors, Br. J. Haematol, vol.112, pp.438-448, 2001.

R. S. Taichman, M. J. Reilly, R. S. Verma, and S. G. Emerson, Augmented production of interleukin-6 by normal human osteoblasts in response to CD34+ hematopoietic bone marrow cells in vitro, Blood, vol.89, pp.1165-1172, 1997.

K. Takahashi, Y. , and S. , Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, vol.126, pp.663-676, 2006.

S. G. Tangye, J. H. Phillips, and L. L. Lanier, The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells, Semin. Immunol, vol.12, pp.149-157, 2000.

B. J. Tauro, D. W. Greening, R. A. Mathias, H. Ji, S. Mathivanan et al., Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes, Methods, vol.56, pp.293-304, 2012.

D. D. Taylor, H. D. Homesley, and G. J. Doellgast, Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments, Cancer Res, vol.40, pp.4064-4069, 1980.

B. K. Thakur, H. Zhang, A. Becker, I. Matei, Y. Huang et al., Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res, vol.24, pp.766-769, 2014.

C. Théry, S. Amigorena, G. Raposo, C. , and A. , Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids, In Current Protocols in Cell Biology, p.p, 2001.

C. Théry, M. Boussac, P. Véron, P. Ricciardi-castagnoli, G. Raposo et al., Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, J. Immunol, vol.166, pp.7309-7318, 2001.

C. Théry, L. Zitvogel, A. , and S. , Exosomes: composition, biogenesis and function, Nat Rev Immunol, vol.2, pp.569-579, 2002.

C. Théry, S. Amigorena, G. Raposo, C. , and A. , Isolation and characterization of exosomes from cell culture supernatants and biological fluids, Curr Protoc Cell Biol Chapter, 2006.

C. Théry, M. Ostrowski, and E. Segura, Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol, vol.9, pp.581-593, 2009.

H. Tilg, E. Trehu, M. B. Atkins, C. A. Dinarello, and J. W. Mier, Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55, Blood, vol.83, pp.113-118, 1994.

C. Toma, W. R. Wagner, S. Bowry, A. Schwartz, and F. Villanueva, Fate Of CultureExpanded Mesenchymal Stem Cells in The Microvasculature, Circulation Research, vol.104, pp.398-402, 2009.

N. J. Topham and E. W. Hewitt, Natural killer cell cytotoxicity: how do they pull the trigger?, Immunology, vol.128, pp.7-15, 2009.

E. Traggiai, S. Volpi, F. Schena, M. Gattorno, F. Ferlito et al., Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients, Stem Cells, vol.26, pp.562-569, 2008.

P. Trivedi and P. Hematti, Derivation and Immunological Characterization of Mesenchymal Stromal Cells from Human Embryonic Stem Cells, Experimental Hematology, vol.36, p.350, 2008.

W. T. Tse, J. D. Pendleton, W. M. Beyer, M. C. Egalka, and E. C. Guinan, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, vol.75, pp.389-397, 2003.

P. D. Tsirigotis, I. B. Resnick, and M. Y. Shapira, the role of NK cell interaction, Ann. Med, vol.44, pp.130-145, 2012.

N. Tufton, S. Ahmad, C. Rolfe, R. Rajkariar, C. Byrne et al., New-onset diabetes after renal transplantation, Diabet. Med, vol.31, pp.1284-1292, 2014.

C. Ungerer, P. Quade-lyssy, H. H. Radeke, R. Henschler, C. Königs et al., Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations, Stem Cells Dev, vol.23, pp.755-766, 2014.

H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee et al., Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol, vol.9, pp.654-659, 2007.

K. C. Vallabhaneni, P. Penfornis, S. Dhule, F. Guillonneau, K. V. Adams et al., Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites, Oncotarget, vol.6, pp.4953-4967, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01179843

C. H. Van-elssen, J. Vanderlocht, T. Oth, B. L. Senden-gijsbers, W. T. Germeraad et al., Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation, Blood, vol.118, pp.2473-2482, 2011.

C. Vater, P. Kasten, and M. Stiehler, Culture media for the differentiation of mesenchymal stromal cells, Acta Biomater, vol.7, pp.463-477, 2011.

J. Villard, The role of natural killer cells in human solid organ and tissue transplantation, J Innate Immun, vol.3, pp.395-402, 2011.

E. Vivier, P. Morin, C. O"brien, B. Druker, S. F. Schlossman et al., Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing, J. Immunol, vol.146, pp.206-210, 1991.

E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, Functions of natural killer cells, Nat. Immunol, vol.9, pp.503-510, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00294184

A. V. Vlassov, S. Magdaleno, R. Setterquist, C. , and R. , Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, Biochim. Biophys. Acta, vol.1820, pp.940-948, 2012.

I. Waldhauer and A. Steinle, NK cells and cancer immunosurveillance, Oncogene, vol.27, pp.5932-5943, 2008.

Y. Y. Wan and R. A. Flavell, How diverse--CD4 effector T cells and their functions, J Mol Cell Biol, vol.1, pp.20-36, 2009.

H. Wang, S. Hung, S. Peng, C. Huang, H. Wei et al., Mesenchymal stem cells in the Wharton"s jelly of the human umbilical cord, Stem Cells, vol.22, pp.1330-1337, 2004.

J. Wang, L. Liao, and J. Tan, Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions, Expert Opin Biol Ther, vol.11, pp.893-909, 2011.

Q. Wang, B. Sun, D. Wang, Y. Ji, Q. Kong et al., Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance, Scand. J. Immunol, vol.68, pp.607-615, 2008.

C. M. Waters and B. L. Bassler, Quorum sensing: cell-to-cell communication in bacteria, Annu. Rev. Cell Dev. Biol, vol.21, pp.319-346, 2005.

P. Wolf, The Nature and Significance of Platelet Products in Human Plasma, British Journal of Haematology, vol.13, pp.269-288, 1967.

K. J. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nat. Rev. Immunol, vol.12, pp.417-430, 2012.

J. Wu, Y. Song, A. B. Bakker, S. Bauer, T. Spies et al., An activating immunoreceptor complex formed by NKG2D and DAP10, Science, vol.285, pp.730-732, 1999.

Z. Xing, J. Gauldie, G. Cox, H. Baumann, M. Jordana et al., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses, J. Clin. Invest, vol.101, pp.311-320, 1998.

M. Yáñez-mó, P. R. Siljander, .. Andreu, Z. Zavec, A. B. Borràs et al., Biological properties of extracellular vesicles and their physiological functions, J Extracell Vesicles, vol.4, p.27066, 2015.

L. Yang, Y. Pang, and H. L. Moses, TGF? and immune cells: an important regulatory axis in the tumor microenvironment and progression, Trends Immunol, vol.31, pp.220-227, 2010.

S. Yang, W. Li, W. Liu, C. Gao, B. Zhou et al., IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis, Clin. Immunol, vol.121, pp.63-73, 2006.

Y. Yeo, R. W. Chai, R. Hian, K. Kiang, and S. , Exosome: A Novel and Safer Therapeutic Refinement of Mesenchymal Stem Cell, Exosomes and Microvesicles, vol.1, 2013.

R. W. Yeo, R. C. Lai, B. Zhang, S. S. Tan, Y. Yin et al., Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery, Adv. Drug Deliv. Rev, vol.65, pp.336-341, 2013.

A. Yoshimura and G. Muto, TGF? function in immune suppression, Curr. Top. Microbiol. Immunol, vol.350, pp.127-147, 2011.

B. Yu, X. Zhang, L. , and X. , Exosomes Derived from Mesenchymal Stem Cells, Int J Mol Sci, vol.15, pp.4142-4157, 2014.

J. Yu, A. G. Freud, and M. A. Caligiuri, Location and cellular stages of natural killer cell development, Trends Immunol, vol.34, pp.573-582, 2013.

U. J. Yun, S. E. Park, Y. S. Jo, J. Kim, and D. Y. Shin, DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors, Cancer Lett, vol.323, pp.155-160, 2012.

M. P. Zaborowski, L. Balaj, X. O. Breakefield, and C. P. Lai, Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study. BioScience biv084, 2015.

L. Zamai, M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri et al., Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells, J. Exp. Med, vol.188, pp.2375-2380, 1998.

E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni et al., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood, vol.106, pp.1755-1761, 2005.

B. Zhang, Y. Yin, R. C. Lai, S. S. Tan, A. B. Choo et al., Mesenchymal stem cells secrete immunologically active exosomes, Stem Cells Dev, vol.23, pp.1233-1244, 2014.

B. Zhang, Y. Yin, R. C. Lai, and S. K. Lim, Immunotherapeutic potential of extracellular vesicles, Front Immunol, vol.5, p.518, 2014.

J. Zhang, C. Niu, L. Ye, H. Huang, X. He et al., Identification of the haematopoietic stem cell niche and control of the niche size, Nature, vol.425, pp.836-841, 2003.

W. Zhang, W. Ge, C. Li, S. You, L. Liao et al., Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells, Stem Cells Dev, vol.13, pp.263-271, 2004.

Q. Zhao, H. Ren, and Z. Han, Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases, Journal of Cellular Immunotherapy, vol.2, pp.3-20, 2016.

Z. Zhao, W. Xu, L. Sun, Y. You, F. Li et al., Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells, Immunol. Invest, vol.41, pp.183-198, 2012.

Y. Zhu, X. Feng, J. Abbott, X. Fang, Q. Hao et al., Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice, Stem Cells, vol.32, pp.116-125, 2014.

C. Zischek, H. Niess, I. Ischenko, C. Conrad, R. Huss et al., Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma, Ann. Surg, vol.250, pp.747-753, 2009.

P. A. Zuk, M. Zhu, H. Mizuno, J. Huang, J. W. Futrell et al., Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, vol.7, pp.211-228, 2001.